Lamivudine
- Product NDC
- 60687-362
- 11-digit product format
- 606870362
- Labeler code
- 60687
- Product ID
- 60687-362_b4f388a6-1506-41f9-e053-2a95a90a529a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA077464
- Marketing category
- ANDA
- Marketing start
- 2018-04-20
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-362-21 | 60687036221 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-362-21) > 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-362-11) | 30 blister pack | 2018-04-20 | 0000-00-00 | No | No | Current |